eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Molnlycke Health Care

Two Omega Drive, Irlam, Manchester, M44 5BJ , UK
Telephone: +44 (0)161 777 2600
Fax: +44 (0)161 777 2601
WWW: http://www.molnlycke.com
Medical Information Direct Line: +44 (0)161 777 2628
Medical Information e-mail: ukmedical.information@molnlycke.com
Customer Care direct line: +44 (0)161 777 2600
Medical Information Fax: +44 (0)161 621 2045

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 20/09/2005
SPC Betadine Ointment


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Betadine Ointment.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Povidone Iodine 10% w/w.


Go to top of the page
3. PHARMACEUTICAL FORM

Ointment.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Betadine Ointment is a broad-spectrum antiseptic for the topical treatment or prevention of infection in minor cuts and abrasions, minor surgical procedures and small areas of burns. Treatment of mycotic and bacterial skin infections and pyodermas. Treatment of infections in decubitus and stasis ulcers.


Go to top of the page
4.2 Posology and method of administration

Route of administration: Topical. For the treatment of infection: Apply once or twice daily for a maximum of 14 days. For the prevention of infection: Apply once or twice a week for as long as necessary. The affected skin should be cleaned and dried. Apply Betadine Ointment to the affected area. May be covered with a dressing or bandage. Not for use in children under two years of age.


Go to top of the page
4.3 Contraindications

Known or suspected iodine hypersensitivity. Regular use is contraindicated in patients and users with thyroid disorders (in particular nodular colloidal goitre, endemic goitre and Hashimoto's thyroiditis). Not for use in children under two years of age.


Go to top of the page
4.4 Special warnings and precautions for use

Special caution is needed when regular applications to broken skin are made to patients with pre-existing renal insufficiency. Regular use should be avoided in patients on concurrent lithium therapy. Thyroid function tests should be performed during prolonged use.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Absorption of iodine from povidone iodine through either intact or damaged skin may interfere with thyroid function tests. Contamination with povidone iodine of several types of tests for the detection of occult blood in faeces or blood in urine may produce false-positive results.


Go to top of the page
4.6 Pregnancy and lactation

Regular use of povidone iodine should be avoided in pregnant or lactating women as absorbed iodine can cross the placental barrier and can be secreted into breast milk. Although no adverse effects have been reported from limited use, caution should be recommended and therapeutic benefit must be balanced against possible effects of the absorption on foetal thyroid function and development.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Povidone iodine may produce local skin reactions although it is considered to be less irritant than iodine. The application of povidone iodine to large wounds or severe burns may produce systemic adverse effects such as metabolic acidosis, hypernatraemia and impairment of renal function.


Go to top of the page
4.9 Overdose

Excess iodine can produce goitre and hypothyroidism or hyperthyroidism. Systemic absorption of iodine after repeated application of povidone iodine to large areas of wounds or burns may lead to a number of adverse effects: metallic taste in mouth, increased salivation, burning or pain in the throat or mouth, irritation and swelling of the eyes, pulmonary oedema, skin reactions, gastrointestinal upset and diarrhoea, metabolic acidosis, hypernatraemia and renal impairment.

Treatment: In the case of deliberate or accidental ingestion of large quantities of Betadine, symptomatic and supportive treatment should be provided with special attention to electrolyte balance and renal and thyroid function.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Povidone iodine is a complex of iodine, which retains the broad-spectrum germicidal activity of elemental iodine without its disadvantages. The germicidal activity is maintained in the presence of blood, pus, serum and necrotic tissue.


Go to top of the page
5.2 Pharmacokinetic properties

Betadine Ointment is applied topically to the affected area.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Polyethylene glycol 4000; polyethylene glycol 1000; polyethylene glycol 1500; purified water; sodium bicarbonate; polyethylene glycol 400.


Go to top of the page
6.2 Incompatibilities

None.


Go to top of the page
6.3 Shelf life

36 months unopened.


Go to top of the page
6.4 Special precautions for storage

Store at or below 25oC.


Go to top of the page
6.5 Nature and contents of container

Triple epoxy lacquered aluminium tubes with polyethylene closures containing 20 or 80g of product.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Seton Healthcare Group plc, Tubiton House, Oldham, OL1 3HS.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0223/0015.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

21st July 1993 / 11th November 2003.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

November 2003.



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1955/SPC/


Active Ingredients/Generics

 
   povidone iodine